ArticleDiscover oncology2024

TCBIR/CD320: a potential therapeutic target upregulated in endothelial cells and associated with immune cell infiltration in liver hepatocellular carcinoma.

Shubin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.